DRNA insider trading

Dicerna Pharmaceuticals Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
391
Last 90 days
0
Buys / sells
2% / 37%
Market cap

DRNA insider activity at a glance

FilingIQ has scored 391 insider transactions for DRNA since Jan 9, 2015. The most recent filing in our index is dated Dec 28, 2021.

Across the full history, 8 open-market purchases and 146 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on DRNA insider trades is 65.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Frequently asked

How many insider trades does FilingIQ track for DRNA?
FilingIQ tracks 391 Form 4 insider transactions for DRNA (Dicerna Pharmaceuticals Inc), covering filings from Jan 9, 2015 onwards. 0 of those were filed in the last 90 days.
Are DRNA insiders net buyers or net sellers?
Across the full Form 4 history for DRNA, 8 transactions (2%) were open-market purchases and 146 (37%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DRNA insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every DRNA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.